Michael Shawn Moran - Feb 2, 2022 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
EVP, Chief Commercial Officer
Signature
/s/ Brian Cahill, Attorney-in-Fact
Stock symbol
EGRX
Transactions as of
Feb 2, 2022
Transactions value $
-$33,412
Form type
4
Date filed
2/4/2022, 03:57 PM
Previous filing
Feb 1, 2022
Next filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Tax liability -$33.4K -742 -3.3% $45.03 21.7K Feb 2, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy withholding tax obligations.